Urgent Recall: Over 11,100 Bottles of Blood Pressure Drug Affected

URGENT UPDATE: A major recall has been issued affecting over 11,100 bottles of the widely-used blood pressure medication, Ziac, due to concerns of potential cross-contamination with another drug. Glenmark Pharmaceuticals Inc. announced the recall following a notice published by the Food and Drug Administration (FDA) earlier today.

The specific concern involves potential contamination with ezetimibe, a medication commonly used to treat high cholesterol. This alarming development could impact patients relying on Ziac—composed of bisoprolol fumarate and hydrochlorothiazide—for managing their hypertension.

The FDA classified this recall as Class III, indicating that exposure to the affected product is “not likely to cause adverse health consequences.” However, the uncertainty surrounding the medication has raised concerns among patients and healthcare providers alike. The recall affects the following specific lot numbers with expiration dates ranging from November 2025 to May 2026:
– 30-count bottles (NDC-68462-878-30)
– 100-count bottles (NDC-68462-878-01)
– 500-count bottles (NDC-68462-878-05)

As of now, the FDA has not provided guidance on what patients should do if they possess the affected medication. Glenmark Pharmaceuticals has been contacted for further comment, but no additional information is available at this time.

This recall raises urgent questions for those relying on this medication for managing blood pressure. The impact of this recall could be significant, as bisoprolol/hydrochlorothiazide is a staple in hypertension treatment regimens.

Healthcare professionals and patients are urged to monitor further updates from the FDA and Glenmark Pharmaceuticals as this situation develops. The safety of patients remains the top priority, and many may need to consult with their healthcare providers regarding alternative treatment options.

Stay tuned for more updates on this urgent matter, as the implications for public health could be far-reaching.